Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care

Osami Kawarada; Kan Zen; Koji Hozawa; Shinobu Ayabe; Hsuan Li Huang; Donghoon Choi; Su Hong Kim; Jiyoun Kim; Taku Kato; Yoshinori Tsubakimoto; Tasuya Nakama; Shigeo Ichihashi; Naoki Fujimura; Akihiro Higashimori; Masahiko Fujihara; Tomoyasu Sato; Bryan Ping Yen Yan; Skyi Yin Chun Pang; Chumpol Wongwanit; Yew Pung Leong; Benjamin Chua; Robbie K. George; Yoshiaki Yokoi; Hisashi Motomura; Hideaki Obara

doi:10.1007/s12928-018-0523-z

Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care

Osami Kawarada, Kan Zen, Koji Hozawa, Shinobu Ayabe, Hsuan Li Huang, Donghoon Choi, Su Hong Kim, Jiyoun Kim, Taku Kato, Yoshinori Tsubakimoto, Tasuya Nakama, Shigeo Ichihashi, Naoki Fujimura, Akihiro Higashimori, Masahiko Fujihara, Tomoyasu Sato, Bryan Ping Yen Yan, Skyi Yin Chun Pang, Chumpol Wongwanit, Yew Pung LeongBenjamin Chua, Robbie K. George, Yoshiaki Yokoi, Hisashi Motomura, Hideaki Obara

Department of Internal Medicine

Research output: Contribution to journal › Review article › peer-review

15 Citations (Scopus)

Abstract

The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.

Original language	English
Pages (from-to)	297-312
Number of pages	16
Journal	Cardiovascular Intervention and Therapeutics
Volume	33
Issue number	4
DOIs	https://doi.org/10.1007/s12928-018-0523-z
Publication status	Published - 2018 Oct 1

Bibliographical note

Funding Information:
Acknowledgements This article was supported in part by Endovascu-lar Asia, a nonprofit physician education and research meeting.

Funding Information:
Conflict of interest Osami Kawarada reports honorarium for lectures and advisory board fees from Boston Scientific Corporation, honorarium for lectures and research grants from Terumo, and a consultancy fee from Medtronic. Hsuan-Li Huang reports honorarium for lectures from Boston Scientific and Medtronic. Testuya Nakama reports honorarium for lectures from Abbott Vascular, Boston Scientific, and Medtronic and consulting fee from Boston Scientific and Century Medical Inc. Naoki Fujimura reports consulting fee from W.L. Gore and Associates. Bryan Ping-Yen Yan reports honorarium for lectures from Boston Scientific Corporation, Cook Medical, and Medtronic, research grants from Medtronic and Boston Scientific Corporation, and consultancy fee from Medtronic and Cook Medical. Robbie K George reports honorariums for/consultancy agreements with Medtronic Corporation, Bard Corporation, Cook Medical, and Abbot Vascular. Kan Zen, Shinobu Aayabe, Donghoon Choi, Su Hong Kim, Jiyoun Kim, Taku Kato, Yoshinori Tsubakimoto, Shigeo Ichihashi, Akihiro Higashimori, Masahiko Fuji-hara, Tomoyasu Sato, Skyi Yin-Chun Pang, Chumpol Wongwanit, Yew Pung Leong, Benjamin Chua, Yoshiaki Yokoi, Hisashi Motomura, and Hideaki Obara report no conflict of interest.

Publisher Copyright:
© 2018, The Author(s).

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Access to Document

10.1007/s12928-018-0523-z

Fingerprint Dive into the research topics of 'Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care'. Together they form a unique fingerprint.

Cite this

Kawarada, O., Zen, K., Hozawa, K., Ayabe, S., Huang, H. L., Choi, D., Kim, S. H., Kim, J., Kato, T., Tsubakimoto, Y., Nakama, T., Ichihashi, S., Fujimura, N., Higashimori, A., Fujihara, M., Sato, T., Yan, B. P. Y., Pang, S. Y. C., Wongwanit, C., ... Obara, H. (2018). Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care. Cardiovascular Intervention and Therapeutics, 33(4), 297-312. https://doi.org/10.1007/s12928-018-0523-z

Kawarada, Osami ; Zen, Kan ; Hozawa, Koji ; Ayabe, Shinobu ; Huang, Hsuan Li ; Choi, Donghoon ; Kim, Su Hong ; Kim, Jiyoun ; Kato, Taku ; Tsubakimoto, Yoshinori ; Nakama, Tasuya ; Ichihashi, Shigeo ; Fujimura, Naoki ; Higashimori, Akihiro ; Fujihara, Masahiko ; Sato, Tomoyasu ; Yan, Bryan Ping Yen ; Pang, Skyi Yin Chun ; Wongwanit, Chumpol ; Leong, Yew Pung ; Chua, Benjamin ; George, Robbie K. ; Yokoi, Yoshiaki ; Motomura, Hisashi ; Obara, Hideaki. / Contemporary critical limb ischemia : Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care. In: Cardiovascular Intervention and Therapeutics. 2018 ; Vol. 33, No. 4. pp. 297-312.

@article{a4f4985d05d8411b8df6cdcb57166b75,

title = "Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care",

abstract = "The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.",

author = "Osami Kawarada and Kan Zen and Koji Hozawa and Shinobu Ayabe and Huang, {Hsuan Li} and Donghoon Choi and Kim, {Su Hong} and Jiyoun Kim and Taku Kato and Yoshinori Tsubakimoto and Tasuya Nakama and Shigeo Ichihashi and Naoki Fujimura and Akihiro Higashimori and Masahiko Fujihara and Tomoyasu Sato and Yan, {Bryan Ping Yen} and Pang, {Skyi Yin Chun} and Chumpol Wongwanit and Leong, {Yew Pung} and Benjamin Chua and George, {Robbie K.} and Yoshiaki Yokoi and Hisashi Motomura and Hideaki Obara",

note = "Funding Information: Acknowledgements This article was supported in part by Endovascu-lar Asia, a nonprofit physician education and research meeting. Funding Information: Conflict of interest Osami Kawarada reports honorarium for lectures and advisory board fees from Boston Scientific Corporation, honorarium for lectures and research grants from Terumo, and a consultancy fee from Medtronic. Hsuan-Li Huang reports honorarium for lectures from Boston Scientific and Medtronic. Testuya Nakama reports honorarium for lectures from Abbott Vascular, Boston Scientific, and Medtronic and consulting fee from Boston Scientific and Century Medical Inc. Naoki Fujimura reports consulting fee from W.L. Gore and Associates. Bryan Ping-Yen Yan reports honorarium for lectures from Boston Scientific Corporation, Cook Medical, and Medtronic, research grants from Medtronic and Boston Scientific Corporation, and consultancy fee from Medtronic and Cook Medical. Robbie K George reports honorariums for/consultancy agreements with Medtronic Corporation, Bard Corporation, Cook Medical, and Abbot Vascular. Kan Zen, Shinobu Aayabe, Donghoon Choi, Su Hong Kim, Jiyoun Kim, Taku Kato, Yoshinori Tsubakimoto, Shigeo Ichihashi, Akihiro Higashimori, Masahiko Fuji-hara, Tomoyasu Sato, Skyi Yin-Chun Pang, Chumpol Wongwanit, Yew Pung Leong, Benjamin Chua, Yoshiaki Yokoi, Hisashi Motomura, and Hideaki Obara report no conflict of interest. Publisher Copyright: {\textcopyright} 2018, The Author(s).",

year = "2018",

month = oct,

day = "1",

doi = "10.1007/s12928-018-0523-z",

language = "English",

volume = "33",

pages = "297--312",

journal = "Cardiovascular Intervention and Therapeutics",

issn = "1868-4300",

publisher = "Springer Verlag",

number = "4",

}

Kawarada, O, Zen, K, Hozawa, K, Ayabe, S, Huang, HL, Choi, D, Kim, SH, Kim, J, Kato, T, Tsubakimoto, Y, Nakama, T, Ichihashi, S, Fujimura, N, Higashimori, A, Fujihara, M, Sato, T, Yan, BPY, Pang, SYC, Wongwanit, C, Leong, YP, Chua, B, George, RK, Yokoi, Y, Motomura, H & Obara, H 2018, 'Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care', Cardiovascular Intervention and Therapeutics, vol. 33, no. 4, pp. 297-312. https://doi.org/10.1007/s12928-018-0523-z

Contemporary critical limb ischemia : Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care. / Kawarada, Osami; Zen, Kan; Hozawa, Koji; Ayabe, Shinobu; Huang, Hsuan Li; Choi, Donghoon; Kim, Su Hong; Kim, Jiyoun; Kato, Taku; Tsubakimoto, Yoshinori; Nakama, Tasuya; Ichihashi, Shigeo; Fujimura, Naoki; Higashimori, Akihiro; Fujihara, Masahiko; Sato, Tomoyasu; Yan, Bryan Ping Yen; Pang, Skyi Yin Chun; Wongwanit, Chumpol; Leong, Yew Pung; Chua, Benjamin; George, Robbie K.; Yokoi, Yoshiaki; Motomura, Hisashi; Obara, Hideaki.

In: Cardiovascular Intervention and Therapeutics, Vol. 33, No. 4, 01.10.2018, p. 297-312.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Contemporary critical limb ischemia

T2 - Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care

AU - Kawarada, Osami

AU - Zen, Kan

AU - Hozawa, Koji

AU - Ayabe, Shinobu

AU - Huang, Hsuan Li

AU - Choi, Donghoon

AU - Kim, Su Hong

AU - Kim, Jiyoun

AU - Kato, Taku

AU - Tsubakimoto, Yoshinori

AU - Nakama, Tasuya

AU - Ichihashi, Shigeo

AU - Fujimura, Naoki

AU - Higashimori, Akihiro

AU - Fujihara, Masahiko

AU - Sato, Tomoyasu

AU - Yan, Bryan Ping Yen

AU - Pang, Skyi Yin Chun

AU - Wongwanit, Chumpol

AU - Leong, Yew Pung

AU - Chua, Benjamin

AU - George, Robbie K.

AU - Yokoi, Yoshiaki

AU - Motomura, Hisashi

AU - Obara, Hideaki

N1 - Funding Information: Acknowledgements This article was supported in part by Endovascu-lar Asia, a nonprofit physician education and research meeting. Funding Information: Conflict of interest Osami Kawarada reports honorarium for lectures and advisory board fees from Boston Scientific Corporation, honorarium for lectures and research grants from Terumo, and a consultancy fee from Medtronic. Hsuan-Li Huang reports honorarium for lectures from Boston Scientific and Medtronic. Testuya Nakama reports honorarium for lectures from Abbott Vascular, Boston Scientific, and Medtronic and consulting fee from Boston Scientific and Century Medical Inc. Naoki Fujimura reports consulting fee from W.L. Gore and Associates. Bryan Ping-Yen Yan reports honorarium for lectures from Boston Scientific Corporation, Cook Medical, and Medtronic, research grants from Medtronic and Boston Scientific Corporation, and consultancy fee from Medtronic and Cook Medical. Robbie K George reports honorariums for/consultancy agreements with Medtronic Corporation, Bard Corporation, Cook Medical, and Abbot Vascular. Kan Zen, Shinobu Aayabe, Donghoon Choi, Su Hong Kim, Jiyoun Kim, Taku Kato, Yoshinori Tsubakimoto, Shigeo Ichihashi, Akihiro Higashimori, Masahiko Fuji-hara, Tomoyasu Sato, Skyi Yin-Chun Pang, Chumpol Wongwanit, Yew Pung Leong, Benjamin Chua, Yoshiaki Yokoi, Hisashi Motomura, and Hideaki Obara report no conflict of interest. Publisher Copyright: © 2018, The Author(s).

PY - 2018/10/1

Y1 - 2018/10/1

N2 - The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.

AB - The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.

UR - http://www.scopus.com/inward/record.url?scp=85053243471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053243471&partnerID=8YFLogxK

U2 - 10.1007/s12928-018-0523-z

DO - 10.1007/s12928-018-0523-z

M3 - Review article

C2 - 29654408

AN - SCOPUS:85053243471

VL - 33

SP - 297

EP - 312

JO - Cardiovascular Intervention and Therapeutics

JF - Cardiovascular Intervention and Therapeutics

SN - 1868-4300

IS - 4

ER -

Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this